参考文献/References:
[1] Yang B,Yuan M,Yang T,et al.Transarterial chemoembolization vs.liver resection as initial treatment for hepatocellular carcinoma occurring exclusively in caudate lobe:a retrospective propensity matching analysis[J].Oncol Res,2022,30:23-33.
[2]Ke S.Advances in the interventional therapy of hepatocellular carcinoma originating from the caudate lobe[J].J Interv Med,2022,5:51-56.
[3]郭玮平,王 杰,管一伟,等.肝动脉化疗栓塞联合微波消融与外科根治性切除治疗小肝癌的对照研究[J].介入放射学杂志,2019,28:642-646.
Guo WP,Wang J,Guan YW,et al.A controlled study on hepatic arterial chemoembolization combined with microwave ablation and surgical radical resection in the treatment of small liver cancer[J].J Interv Radiol,2019,28:642-646.
[4]Kotsifa E,Vergadis C,Vailas M,et al.Transarterial chemoembolization for hepatocellular carcinoma:Why,When,How?[J].J Pers Med,2022,12:436.
[5]《原发性肝癌诊疗指南(2024年版)》编写专家委员会.原发性肝癌诊疗指南(2024 年版)[J].中国临床医学,2024,31:277-334.
Expert committee of guideline for the diagnosis and treatment of primary liver cancer(2024 edition).Guideline for the diagnosis and treatment of primary liver cancer(2024 edition)[J].Chin J Clin Med,2024,31:277-334.
[6]Su GL,Altayar O,O'Shea R,et al.AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma[J].Gastroenterology,2022,162:920-934.
[7]Kim M N,Kim B K,Han K,et al.Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma:considerations for tumor response assessment[J].Expert Rev Gastroenterol Hepatol,2015,9:335-348.
[8]Zensen S,Bücker A,Meetschen M,et al.Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors:lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy(DeGIR)2018-2022[J].Eur Radiol,2024,34:3322-3330.
[9]Ding Y,Chang T,Shen C,et al.Survival benefit of sequential curative treatment for TACE suitable BCLC stage BHCC patients[J].Sci Rep,2024,14:22588.
[10]Makary M S,Khandpur U,Cloyd J M,et al.Locoregional therapy approaches for hepatocellular carcinoma:recent advances and management strategies[J].Cancers(Basel),2020,12:1914.
[11]Kim H,Chung J W,Jae H J,et al.Caudate lobe hepatocellular carcinoma treated with selective chemoembolization[J].Radiology,2010,257:278-287.
[12]李姗姗,李开艳,黄 哲,等.特殊部位小肝癌超声引导下微波消融与手术切除的对比研究[J].介入放射学杂志,2021,30:784-787.
Li SS,Li KY,Huang Z,et al.Comparative study of ultrasound-guided microwave ablation and surgical resection of small liver cancer in special areas[J].J Intervent Radiol,2021,30:784-787.
[13]Cao S,Zou Y,Lyu T,et al.Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm:emphasis on local tumor progression[J].Int J Hyperthermia,2022,39:1-7.
[14]袁宏军,刘凤永,李 鑫,等.超选择性肝动脉化学治疗栓塞治疗13例尾状叶肝癌的疗效评价[J].中华肝脏病杂志,2017,25:744-748.
Yuan HJ,Liu FY,Li X,et al.Clinical effect of ultraselective transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma originating from the caudate lobe:an analysis of 13 cases[J].Chinese Journal of Hepatology,2017,25:744-748.
[15]Fujimori M,Takaki H,Nakatsuka A,et al.Combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe[J].J Vasc Interv Radiol,2012,23:1622-1628.
(收稿日期:2025-06-19)
(本文编辑:谷 珂)
相似文献/References:
[1]郭丽萍,张晓玲,王莉娜.经导管肝动脉化疗栓塞联合高强度聚焦超声治疗原发性肝癌的护理[J].介入放射学杂志,2010,(04):328.
GUO Liping,ZHANG Xiaoling,WANG Lina.The nursing care for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization and high intensive focus ultrasound[J].J Intervent Med,2010,(03):328.
[2]沈海洋,杨光,刘瑞宝,等.肝右叶前、后段原发性肝癌动脉化疗栓塞术后近期疗效比较[J].介入放射学杂志,2010,(05):382.
SHEN Haiyang,YANG Guang,LIU Ruibao,et al.Short－term effects of TACE for primary hepatocellular carcinoma of the right hepatic lobe：a comparison between the lesions in anterior segments and the lesions in posterior segments[J].J Intervent Med,2010,(03):382.
[3]池嘉昌,沈加林,许建荣,等.全肝CT灌注成像在原发性肝癌TACE术后局部病灶活性评估中的临床应用[J].介入放射学杂志,2010,(07):540.
CHI Jiachang,SHEN Jialin,XU Jianrong,et al.Clinical application of whole－liver perfusion－enhanced CT imaging in evaluating the activity of residual hepatocellular carcinoma after TACE[J].J Intervent Med,2010,(03):540.
[4]翁志成,杨维竹,江娜,等.CT引导下１２５I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价[J].介入放射学杂志,2010,(07):535.
WENG Zhicheng,YANG Weizhu,JIANG Na,et al.Evaluation of CT－guided１２５I seed implantation combined with transcatheter arterial chemoem－bolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma[J].J Intervent Med,2010,(03):535.
[5]王悍 王精兵 张贵祥 王麟川.肝细胞癌动脉化疗栓塞术后并发脑梗死一例[J].介入放射学杂志,2005,(04):442.
WANG Han WANG Jing-bing ZHANG Gui-xiang WANG Lin-chuan.Cerebral infarction aften transaterial shemoembolization for hepatocellular carcinoma a cage report[J].J Intervent Med,2005,(03):442.
[6]张绪敬,程佩芳,董光,等.原发性肝癌经导管化疗、栓塞前后血中凝血酶原变化的研究[J].介入放射学杂志,1992,(01):33.
[7]欧阳墉,马和平,张学军,等.肝细胞癌的鉴别诊断——附10例分析[J].介入放射学杂志,1996,(01):40.
[8]周斌,李征然,钱结胜,等.原发性肝癌肝移植后肿瘤复发的化疗栓塞治疗[J].介入放射学杂志,2009,(03):185.
ZHOU Bin,LI Zhengran,QIAN Jiesheng,et al.Chemoembolization for recurrent hepatocellular carcinoma after liver transplantation[J].J Intervent Med,2009,(03):185.
[9]黄渊全,贾中芝,冯耀良,等.CT灌注成像在肝癌TACE术后疗效评价中的应用价值[J].介入放射学杂志,2009,(06):437.
HUANG Yuan-quan,JIA Zhong-zhi,FENG Yao-liang,et al.Clinical application of CT perfusion imaging in estimating the efficacy of transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma[J].J Intervent Med,2009,(03):437.
[10]王惠文,刘瑞宝,刘 岩,等.原发性肝癌ＴＡＣＥ后ＦＡＫ、ＮＦκＢｐ６５表达及意义[J].介入放射学杂志,2011,(08):621.
WANG Hui-wen,LIU Rui-bao,LIU Yan,et al.The expression and significance of FAK and NF-κBp65 in hepatocellular carcinoma after transcatheter arterial chemoembolization[J].J Intervent Med,2011,(03):621.